Bruker (BRKRP) Common Equity (2009 - 2026)

Bruker (BRKRP) has 18 years of Common Equity data on file, last reported at $2.5 billion in Q1 2026.

• For the quarter ending Q1 2026, Common Equity rose 34.6% year-over-year to $2.5 billion; the trailing twelve-month figure through Mar 2026 stood at $2.5 billion (up 34.6% YoY), and the FY2025 full-year result was $2.5 billion, up 37.64% from the prior year.
• Common Equity for Q1 2026 stood at $2.5 billion, roughly flat from $2.5 billion in the prior quarter.
• Across five years, Common Equity topped out at $2.5 billion in Q4 2025 and bottomed at $948.0 million in Q3 2022.
• The 5-year median for Common Equity is $1.4 billion (2024), against an average of $1.6 billion.
• The widest annual swing landed in 2022, when Common Equity retreated 13.0%; it then surged 48.73% in 2024.
• A 5-year view of Common Equity shows it stood at $1.1 billion in 2022, then advanced by 23.89% to $1.4 billion in 2023, then rose by 28.86% to $1.8 billion in 2024, then surged by 37.64% to $2.5 billion in 2025, then decreased by 0.26% to $2.5 billion in 2026.
• The last three Common Equity figures came in at $2.5 billion (Q1 2026), $2.5 billion (Q4 2025), and $2.4 billion (Q3 2025), per Business Quant data.

Peer Comparison